Ly Fatimata, Soko Anta Soumare, Dione Demba Anta, Niang Suzanne Oumou, Kane Assane, Bocoum Thierno Ibrahima, Dieng Mame Thierno, Ndiaye Bassirou
Department of Dermatology/Institute of Social Hygiene, Cheikh Anta Diop University, Dakar, Senegal.
Int J Dermatol. 2007 Oct;46 Suppl 1:15-7. doi: 10.1111/j.1365-4632.2007.03456.x.
The use of skin bleaching products for cosmetic purposes is a frequent practice (25-96%) in women from sub-Saharan Africa. The dermatologic complications associated with this practice have been comprehensively reported. The aim of this work was to study the epidemiologic, clinical, and cosmetic aspects of these complications in order to produce better therapeutic guidelines for their management.
This was a prospective, descriptive study performed over a 6-month period. All women aged between 15 and 50 years, who consulted a dermatologist (Le Dantec Hospital or Institute of Social Hygiene), experienced a complication associated with artificial depigmentation, and agreed to take part in the study, were included. The data were input and analyzed using Epi info version 6.0.
Eighty-six female patients were included, with a mean age of 29.34 years (range, 16-49 years). The breakdown by level of education was as follows: primary (48.8%), secondary (18.3%), and higher (8.5%) education. Twenty-two per cent of our population had not attended school. The mean monthly cost of skin bleaching products was 6.22 euros. The initial skin tone before using skin bleaching products was black in 41.5% of patients, light in 32.9%, and intermediate in 25.6%. The mean duration of exposure was 6.7 +/- 5 years (range, 1-30 years). The breakdown by skin bleaching products showed that topical corticosteroids were the most frequently used (78%), followed by hydroquinone (56%), products based on vegetable extracts (31.7%), caustic products (8.5%), and, finally, products of unknown composition (41.4%). Two components or more were frequently combined (86.5%). The aesthetic complications of artificial depigmentation were the reason for consulting a dermatologist in 10 patients (12%). Nineteen types of aesthetic complication were reported in our sample. Hyperpigmentation of the joints was the most frequently found complication (85.4%), followed by striae atrophicae (72%) and skin atrophy (59.8%). The number of aesthetic complications found in the patients varied from one to nine. Patients frequently presented (71.9%) with other complications associated with artificial depigmentation.
Aesthetic complications associated with artificial depigmentation are common, but rarely the reason for consulting a dermatologist. In the absence of suitable therapeutic agents, prevention, based on informing women of the damaging effects of artificial depigmentation, is the only way forward.
在撒哈拉以南非洲地区,女性出于美容目的使用皮肤美白产品的现象十分普遍(比例为25% - 96%)。与这种做法相关的皮肤并发症已有全面报道。本研究旨在探讨这些并发症的流行病学、临床及美容方面的情况,以便制定出更好的治疗管理指南。
这是一项为期6个月的前瞻性描述性研究。纳入所有年龄在15至50岁之间、因人工色素脱失相关并发症前来皮肤科医生处(勒丹泰克医院或社会卫生研究所)就诊且同意参与研究的女性。数据使用Epi info 6.0版本录入并分析。
共纳入86例女性患者,平均年龄29.34岁(范围为16 - 49岁)。按教育程度划分如下:小学(48.8%)、中学(18.3%)、高等教育(8.5%)。22%的研究对象未接受过学校教育。皮肤美白产品的月平均花费为6.22欧元。使用皮肤美白产品前,41.5%的患者初始肤色为黑色,32.9%为浅色,25.6%为中间色。平均暴露时长为6.7±5年(范围为1 - 30年)。按皮肤美白产品种类划分,外用糖皮质激素是最常用的(78%),其次是对苯二酚(56%)、植物提取物类产品(31.7%)、苛性产品(8.5%),最后是成分不明的产品(41.4%)。两种或更多成分常被联合使用(86.5%)。人工色素脱失的美容并发症是10例患者(12%)咨询皮肤科医生的原因。我们的样本中报告了19种美容并发症。关节色素沉着是最常见的并发症(85.4%),其次是萎缩纹(72%)和皮肤萎缩(59.8%)。患者出现的美容并发症数量从1种到9种不等。患者还常伴有(71.9%)与人工色素脱失相关的其他并发症。
与人工色素脱失相关的美容并发症很常见,但很少是患者咨询皮肤科医生的原因。在缺乏合适治疗药物的情况下,通过告知女性人工色素脱失的有害影响进行预防是唯一的前进方向。